Rheumatoid arthritis, its treatments, and the risk of tuberculosis in Quebec, Canada
β Scribed by Brassard, Paul ;Lowe, Anne-Marie ;Bernatsky, Sasha ;Kezouh, Abbas ;Suissa, Samy
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 71 KB
- Volume
- 61
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract **__Background__**: Mizoribine (MZR), isolated from culture medium of the mold, is a novel immunosuppressant developed in Japan. It has been used in patients with renal transplantation, lupus nephritis, nephrotic syndrome and rheumatoid arthritis (RA). **__Objectives__**: To review M
## Abstract ## Objective According to the Centers for Disease Control and Prevention, the 1999 and 2000 incidence rates for tuberculosis (TB) in the US population were 6.4 and 5.8, respectively, per 100,000 persons. Recently, reports of TB following infliximab administration have raised questions